OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
September 16, 2021
EFSA’s evaluation of risk in food products raises implications for drug product formulations.
September 09, 2021
Moderna announced a collaboration to develop a new mRNA therapeutic for Crigler-Najjar Syndrome Type 1 at no cost to patients.
September 03, 2021
Consistency, robustness, and understanding of the API and controlled-release excipients are essential for successful drug dosing.
The intranasal route of administration is showing clinical promise, particularly for COVID-19, but there are multiple hurdles to overcome to ensure successful formulation.
The potential for okra gum as a polymer candidate for new oral drug formulations was evaluated.
August 31, 2021
The pH effect encountered with oral oncology medication can be overcome with amorphous solid dispersions.
August 03, 2021
Dosage form priorities are shifting to focus on user-friendliness, leading to greater engagement with outsourcing partners earlier in development timelines.
Amorphous solid dispersions can overcome the pH effect encountered with oral oncology medications.
August 02, 2021
Collaborative partnerships can foster success in formulation development projects.
Recent research has highlighted the underlying mechanisms of amorphous solid dispersions and theory behind the formation of drug-rich phases.